Evidence map›Paper›PMID 26864651›Full record

ArticleScientific reports2016

Inhibition of Growth and Metastasis of Colon Cancer by Delivering 5-Fluorouracil-loaded Pluronic P85 Copolymer Micelles.

Pengxi Zhu, Naping Zhao, Dandan Sheng, Jing Hou, Chong Hao, Xue Yang, Bing Zhu, Shanshan Zhang, Zhipeng Han, Lixin Wei and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Djakonoviosides A, AInternational journal of molecular sciences · 2023
    Article
  10. Carrageenans and Their Oligosaccharides from Red SeaweedsInternational journal of molecular sciences · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pengxi ZhuDepartment of Phamacy, Changhai Hospital, the Second Military Medical University, Shanghai, 200433, China.
Naping ZhaoDepartment of Phamacy, Changhai Hospital, the Second Military Medical University, Shanghai, 200433, China.
Dandan ShengDepartment of Phamacy, Changhai Hospital, the Second Military Medical University, Shanghai, 200433, China.
Jing HouDepartment of Phamacy, Changhai Hospital, the Second Military Medical University, Shanghai, 200433, China.
Chong HaoTumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospital, the Second Military Medical University, Shanghai, 200433, China.
Xue YangTumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospital, the Second Military Medical University, Shanghai, 200433, China.
Bing ZhuDepartment of Phamacy, Changhai Hospital, the Second Military Medical University, Shanghai, 200433, China.
Shanshan ZhangTumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospital, the Second Military Medical University, Shanghai, 200433, China.
Zhipeng HanTumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospital, the Second Military Medical University, Shanghai, 200433, China.
Lixin WeiTumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospital, the Second Military Medical University, Shanghai, 200433, China.
Li ZhangDepartment of Phamacy, Changhai Hospital, the Second Military Medical University, Shanghai, 200433, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic metastasis is the leading cause of mortality of colon cancer, which is still lack of an effective therapy. A new delivery system, pluronic P85 block copolymers, conveying chemotherapeutic agent 5-fluorouracil (5-Fu) for inhibiting growth and metastasis of colon cancer was designed and developed. In this study, we demonstrated that 5-Fu produce strong pesticide effect at lower doses in the present of pluronic P85 compared with control groups. The migration and invasion of HCT116 cells and RKO cells were examined and the results showed that migration and invasion capacities of HCT116 cells and RKO cells were reduced by administering 5-Fu/P85 copolymer micelles in vitro and in vivo which indicating an effectively activity. Interestingly, the content of CD133 + CXCR4+ cells in HCT116 cancer cells and RKO cells treated by 5-Fu/P85 copolymer micelles was decreased. Importantly, the epithelial-mesenchymal transition (EMT) of CD133 + CXCR4+ cells, which was strongly associated with liver metastasis of colon cancer, was also suppressed by giving 5-Fu/P85 copolymer micelles. The results indicated that 5-Fu/P85 copolymer micelles could inhibit the growth and metastasis of colon cancer, which could be attributed to the decrease of the content of CD133 + CXCR4+ cells and suppression of EMT of CD133 + CXCR4+ cells.

Indexed as

Drug CarriersAC133 AntigenAnimalsAntineoplastic AgentsCell Line, TumorCell MovementColonic NeoplasmsDrug CompoundingDrug LiberationFluorouracilGene ExpressionHCT116 CellsHumansInjections, IntravenousLiver NeoplasmsMaleAC133 AntigenAntineoplastic AgentsDrug CarriersFluorouracilMicellespluronic block copolymer p85PoloxaleneReceptors, CXCR4

Identifiers

PMID26864651
PMCPMC4750032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.